PARG1 Antikörper (AA 1-1261)
ARHGAP29
Reaktivität: Human
WB
Wirt: Maus
Polyclonal
unconjugated
-
-
Target
Alle PARG1 (ARHGAP29) Antikörper anzeigen
-
PARG1 (ARHGAP29)
(rho GTPase Activating Protein 29 (ARHGAP29))
-
Bindungsspezifität
-
AA 1-1261
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser PARG1 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB)
-
Verwendungszweck
-
Mouse polyclonal antibody raised against a full-length human ARHGAP29 protein.
-
Sequenz
-
MIAHKQKKTK KKRAWASGQL STDITTSEMG LKSLSSNSIF DPDYIKELVN DIRKFSHMLL YLKEAIFSDC FKEVIHIRLE ELLRVLKSIM NKHQNLNSVD LQNAAEMLTA KVKAVNFTEV NEENKNDLFQ EVFSSIETLA FTFGNILTNF LMGDVGNDSL LRLPVSRETK SFENVSVESV DSSSEKGNFS PLELDNVLLK NTDSIELALS YAKTWSKYTK NIVSWVEKKL NLELESTRNM VKLAEATRTN IGIQEFMPLQ SLFTNALLND IESSHLLQQT IAALQANKFV QPLLGRKNEM EKQRKEIKEL WKQEQNKMLE AENALKKAKL LCMQRQDEYE KAKSSMFRAE EEHLSSSGGL AKNLNKQLEK KRRLEEEALQ KVEEANELYK VCVTNVEERR NDLENTKREI LAQLRTLVFQ CDLTLKAVTV NLFHMQHLQA ASLADSLQSL CDSAKLYDPG QEYSEFVKAT NSTEEEKVDG NVNKHLNSSQ PSGFGPANSL EDVVRLPDSS NKIEEDRCSN SADITGPSFI RSWTFGMFSD SESTGGSSES RSLDSESISP GDFHRKLPRT PSSGTMSSAD DLDEREPPSP SETGPNSLGT FKKTLMSKAA LTHKFRKLRS PTKCRDCEGI VVFQGVECEE CLLVCHRKCL ENLVIICGHQ KLPGKIHLFG AEFTQVAKKE PDGIPFILKI CASEIENRAL CLQGIYRVCG NKIKTEKLCQ ALENGMHLVD ISEFSSHDIC DVLKLYLRQL PEPFILFRLY KEFIDLAKEI QHVNEEQETK KNSLEDKKWP NMCIEINRIL LKSKDLLRQL PASNFNSLHF LIVHLKRVVD HAEENKMNSK NLGVIFGPSL IRPRPTTAPI TISSLAEYSN QARLVEFLIT YSQKIFDGSL QPQDVMCSIG VVDQGCFPKP LLSPEERDIE RSMKSLFFSS KEDIHTSESE SKIFERATSF EESERKQNAL GKCDACLSDK AQLLLDQEAE SASQKIEDGK TPKPLSLKSD RSTNNVERHT PRTKIRPVSL PVDRLLLASP PNERNGRNMG NVNLDKFCKN PAFEGVNRKD AATTVCSKFN GFDQQTLQKI QDKQYEQNSL TAKTTMIMPS ALQEKGVTTS LQISGDHSIN ATQPSKPYAE PVRSVREASE RRSSDSYPLA PVRAPRTLQP QHWTTFYKPH APIISIRGNE EKPASPSAAV PPGTDHDPHG LVVKSMPDPD KASACPGQAT GQPKEDSEEL GLPDVNPMCQ RPRLKRMQQF EDLEDEIPQF V
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody reactive against mammalian transfected lysate.
-
Immunogen
-
ARHGAP29 (NP_004806, 1 a.a. ~ 1261 a.a) full-length human protein.
-
Top Product
-
Discover our top product ARHGAP29 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Buffer
-
No additive
-
Konservierungsmittel
-
Without preservative
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Target
-
PARG1 (ARHGAP29)
(rho GTPase Activating Protein 29 (ARHGAP29))
-
Andere Bezeichnung
-
ARHGAP29 (ARHGAP29 Produkte)
-
Synonyme
-
arhgap29 antikoerper, sb:cb905 antikoerper, zgc:63950 antikoerper, ARHGAP29 antikoerper, PARG1 antikoerper, RP11-255E17.1 antikoerper, 6720461J18Rik antikoerper, A830014I19 antikoerper, AU040217 antikoerper, B130017I01Rik antikoerper, C76601 antikoerper, Parg1 antikoerper, B130017i01rik antikoerper, RGD1306185 antikoerper, Rho GTPase activating protein 29 antikoerper, Rho GTPase activating protein 29b antikoerper, Rho GTPase activating protein 29 S homeolog antikoerper, ARHGAP29 antikoerper, arhgap29b antikoerper, arhgap29.S antikoerper, arhgap29 antikoerper, Arhgap29 antikoerper
-
Hintergrund
-
Full Gene Name: Rho GTPase activating protein 29
Synonyms: PARG1,RP11-255E17.1
-
Gen-ID
-
9411
-
NCBI Accession
-
NM_004815
-